The VAP Test

The VAP Cholesterol Test for Research and Clinical Trials

The VAP in Clinical Research
Atherotech, Inc. is a cardio-diagnostic company offering researchers a unique and valuable analytical research tool-the VAP Cholesterol Test-a direct measured comprehensive lipid assessment. Atherotech is the only laboratory that performs this test.

What Is The VAP Cholesterol Test?
The Vertical Auto Profile, or VAP, Test is the most Comprehensive Lipoprotein Risk Assessment Test for Total Cholesterol/Lipid Management. The VAP Test directly measures risk factors associated with heart disease, providing more accurate information than the routine lipid test, which calculates the LDL value. Additionally, the VAP Test directly measures other cholesterol/lipoproteins which are now widely recognized as independent risk factors. The VAP Test provides more information with greater accuracy.

Current Clinical Research
Atherotech has been involved in research testing for more than 100 clinical research studies. The VAP technology has been chosen for the analysis of more than 65,000 clinical research specimens from a variety of studies. View a list of some of these institutions and studies.

A Note from Our Chief Medical Officer
"We are proud to present an extraordinarily comprehensive, versatile and accurate expanded lipid profile that completely addresses the present and future needs of the modern clinical trialist and CRO. By providing direct measurements of LDL, HDL and all relevant subclasses, emerging risk factors (e.g., Lp (a), LDL pattern, density and size) and precise calculations (e.g. Apo B, Apo A1), we are able to supply the researcher with a full characterization of each subject's risk and a detailed report on the effect of any intervention on lipid composition."

"Given the contemporary excitement about insulin-resistant states, the importance of the triglyceride-HDL axis and the renewed interest in postprandial physiology, Atherotech's VAP© technology is perfectly positioned to partner with investigators who demand reference laboratory accuracy, convenience and cost-effective testing on both fasting and non-fasting samples."

-James Ehrlich, MD, Chief Medical Officer - Atherotech, Inc.

For more information contact us today by phone at 877.901.8510 or email at research@atherotech.com.